Study Condition(s): Advanced Cancer, Solid Tumor

A Study of LY2606368 in Participants With Advanced Cancer

Study Alias: JTJG

Study Identifier(s): Tool Tip Icon {{ defaultRegistry.registryAnchorText }} NCT02778126 {{ currentLocaleObject.registryAnchorText }}

Study Purpose

The main purpose of this study is to evaluate the safety of the study drug known as LY2606368 in participants with advanced cancer or cancer that has spread to other parts of the body.

Key Participation Requirements Tool Tip Icon

All clinical trials have rules about who can participate. This section outlines some of those rules. Please contact a study center to discuss the full set of criteria


Male Female


18+ years

Time Commitment

Your participation could last up to 5 weeks depending on how you and your tumor respond.
  • Participant must have a diagnosis of cancer (solid tumor) confirmed by histology or cytology with clinical or radiologic evidence of locally advanced and/or metastatic disease , for which no life-prolonging therapy exists
  • Participant must not have received treatment within 28 days of the initial dose of study drug with an investigational product or non-approved use of a drug or device
  • Participant must not have symptomatic central nervous system (CNS) malignancy or metastasis
  • Participant must not have current haematologic malignancies or acute or chronic leukemia
  • Participant must not have an active fungal, bacterial, and/or known viral infection
  • Participant must not have participated in a ¹⁴C (carbon) study within the last 6 months prior to screening for this study

Where to Participate

1 locations are currently available of 1 planned
Invalid Postal Code.
Please re-enter postal code.

{{sites.getPageStartCount()}} - {{sites.getPageEndCount()}} of {{sites.totalCount}} Results

0 of {{sites.totalCount}} Results

Distance Location Status
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
Status {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus | translate}}
Closest Location to Participate
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
Status {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus | translate}}
Other Location(s) to Participate
{{site.getDistance() | number:0}} {{convertUnit("imperial", "mile") | translate}} {{convertUnit("imperial", "miles") | translate}}
Status {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus}} {{site.siteStatus | translate}} {{site.getSiteCTALabel() | translate}}

To improve your experience on Lilly TrialGuide, please use the latest version of Chrome, Firefox, Safari, or Internet Explorer, with Java Script enabled.
This website is not optimized for your browser, as configured.